Loading clinical trials...
Loading clinical trials...
Effects of the TNF-alpha Inhibiton on Blood Pressure, Hemodynamic Parameters and Biomarkers in Resistant Hypertension
Conditions
Interventions
Infliximab
Saline
Locations
1
Brazil
University of Campinas (UNICAMP)
Campinas, São Paulo, Brazil
Start Date
March 1, 2015
Primary Completion Date
July 1, 2017
Completion Date
July 1, 2017
Last Updated
November 9, 2017
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
University of Campinas, Brazil
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions